Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:5.99.1.2 (
topoisomerase
)
9,166
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Warsaw Breakage Syndrome (WABS) is a rare disorder related to cohesinopathies and Fanconi anemia, caused by bi-allelic mutations in
DDX11
. Here, we report multiple compound heterozygous WABS cases, each displaying destabilized
DDX11 protein
and residual
DDX11
function at the cellular level. Patient-derived cell lines exhibit sensitivity to
topoisomerase
and PARP inhibitors, defective sister chromatid cohesion and reduced DNA replication fork speed. Deleting
DDX11
in RPE1-TERT cells inhibits proliferation and survival in a TP53-dependent manner and causes chromosome breaks and cohesion defects, independent of the expressed pseudogene DDX12p. Importantly, G-quadruplex (G4) stabilizing compounds induce chromosome breaks and cohesion defects which are strongly aggravated by inactivation of
DDX11
but not FANCJ. The DNA helicase domain of
DDX11
is essential for sister chromatid cohesion and resistance to G4 stabilizers. We propose that
DDX11
is a DNA helicase protecting against G4 induced double-stranded breaks and concomitant loss of cohesion, possibly at DNA replication forks.
...
PMID:Warsaw Breakage Syndrome associated DDX11 helicase resolves G-quadruplex structures to support sister chromatid cohesion. 3285 19